Golden
Opentrons

Opentrons

A company building robots to automate experiments of life scientists

In March 2018, Opentrons announced the launch of its newest lab robot, OT-2 and new no-code Protocol Designer. The OT-2 release is supported by the close of a $10M seed funding round, led by Khosla Ventures with participation from Lerer Hippeau Ventures, Y Combinator Continuity Fund, and Jeff Kindler, former CEO of Pfizer. This launch and financial backing furthers Opentrons' mission to bring affordable automation to any biologist.



Founded out of Brooklyn in 2013, Opentrons's stated goal is to save researchers from having to carry out repetitive tasks.



Timeline

Funding rounds

1 Result
Funding round
Funding round
Funding round amount (USD)
Funding round amount (USD)
Funding type
Funding type
Funding round date
Funding round date
Investment
Investment

People

Name
Role
LinkedIn

Alfie Umbhau

Employee



Andy Sigler

Employee



Artyom Astafurov

Employee



Benjamin Morris

Employee



Chiu Chau

Co-founder, CTO



Chon Tang

Investor



Gil Seton

Investor



Jenny Vu

Employee



Jon Martinez

Employee



Jonathan Badal

CEO



Katie Adee

Employee



Kristin Ellis

Employee



Lev Kravinsky

Employee



Lucy Volland

Employee



Matthew Monsees

Employee



Michelle Steigerwalt

Employee



Mike Cousins

Employee



Mike Fitzgerald

Employee



Mitch Dunn

Employee



Pantea Razzaghi

Employee



Will Canine

Co-founder, CPO



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References